Cancer is the second leading cause of death globally, with drug resistance often leading to relapse and poor outcomes, especially in metastatic cases.
abm's collection of drug-resistant cancer cell lines spans various types and therapies, offering a vital platform for studying resistance, testing treatments, and advancing precision medicine. Visit our knowledge base for more information about cell culture.
| Cat. No. |
Cell Line Name |
1st Line Resistance |
2nd Line Resistance |
Luciferase |
Quantity |
Price |
| Prostate |
| T8355 |
PC-3/TXR |
paclitaxel & docetaxel |
— |
— |
? 40µg (250pmol/ 25µL) |
$80.00 |
| T8356 |
PC-3M Luci/TXR |
paclitaxel & docetaxel |
— |
Luciferase |
|
|
| T8357 |
DU-145/TXR |
paclitaxel & docetaxel |
— |
— |
|
|
| T8358 |
CWR-22/TXR |
paclitaxel & docetaxel |
— |
— |
|
|
| Cervix |
| T8359 |
HeLa Luci/DOX |
doxorubicin |
— |
Luciferase |
|
|
| T8360 |
HeLa Luci/GEM |
gemcitabine |
— |
Luciferase |
|
|
| T8361 |
HeLa Luci/MMC |
mitomycin C |
— |
Luciferase |
|
|
| T8362 |
HeLa Luci/TXR |
paclitaxel & docetaxel |
— |
Luciferase |
|
|
| Bladder |
| T8363 |
KU19-19/DOX |
doxorubicin |
— |
— |
|
|
| T8364 |
KU19-19/TXR |
paclitaxel & docetaxel |
— |
— |
|
|
| T8365 |
KU19-19/GEM |
gemcitabine |
— |
— |
|
|
| T8366 |
KU19-19/MMC |
mitomycin C |
— |
— |
|
|
| T8367 |
KU19-19/DOX/GEM |
doxorubicin |
gemcitabine |
— |
|
|
| T8368 |
KU19-19/DOX/TXR |
doxorubicin |
paclitaxel & docetaxel |
— |
|
|
| T8369 |
KU19-19/DOX/MMC |
doxorubicin |
mitomycin C |
— |
|
|
| T8370 |
KU19-19/TXR/GEM |
paclitaxel & docetaxel |
gemcitabine |
— |
|
|
| T8371 |
KU19-19/TXR/MMC |
paclitaxel & docetaxel |
mitomycin C |
— |
|
|
| T8372 |
KU19-19/GEM/DOX |
gemcitabine |
doxorubicin |
— |
|
|
| T8373 |
KU19-19/GEM/TXR |
gemcitabine |
paclitaxel & docetaxel |
— |
|
|
| T8374 |
KU19-19/GEM/MMC |
gemcitabine |
mitomycin C |
— |
|
|
| T8375 |
KU19-19/MMC/DOX |
mitomycin C |
doxorubicin |
— |
|
|
| T8376 |
KU19-19/MMC/TXR |
mitomycin C |
paclitaxel & docetaxel |
— |
|
|
| T8377 |
KU19-19/MMC/GEM |
mitomycin C |
gemcitabine |
— |
|
|
| T8378 |
T24/DOX |
doxorubicin |
— |
— |
|
|
| T8379 |
T24/TXR |
paclitaxel |
— |
— |
|
|
| T8380 |
UM-UC-3 Luci/TXR |
paclitaxel & docetaxel |
— |
Luciferase |
|
|
| T8381 |
UM-UC-3 Luci/DOX |
doxorubicin |
— |
Luciferase |
|
|
| T8382 |
UM-UC-3 Luci/GEM |
gemcitabine |
— |
Luciferase |
|
|
| T8383 |
UM-UC-3 Luci/MMC |
mitomycin C |
— |
Luciferase |
|
|
|
TXR (paclitaxel & docetaxel), DOX (doxorubicin), GEM (gemcitabine), MMC (mitomycin C), Luci (Luciferase)
|
Resources
-
Performance Data
-
Workflow
-
Knowledge Base
